We just need your registered Email Id
to sent your password reset
instructions.
You're doing something extraordinary. We'll keep you in the loop with our latest news and special offers. Please update your profile on a regular basis and be an active community member. Let others know we exist and together we can move medicine forward.
You are now registered within Modern Trials network. If we receive patient inquires within your zip code we will let you know. Be on the look out for an E-Mail from our team.
| NCT Id | NCT04107428 |
|---|---|
| Title | Somatostatin in Living Donor Liver Transplantation |
| Condition | End Stage Liver DIsease |
| StudyType | Interventional |
| Organization | King Faisal Specialist Hospital & Research Center |
| Sponsor/Collaborators | King Faisal Specialist Hospital & Research Center |
| Status | Not yet recruiting |
| Gender | All |
| AgeGroup | Adult Older Adult |
| Location (with distance) | |
| Description | Aim of the study is to investigate the safety and the efficacy of somatostatin as liver inflow modulator in patients with end-stage liver disease (ESLD) and clinically significant portal hypertension (CSPH) undergoing Adult-to-Adult living donor liver transplantation (A2ALDLT). |
Your interest has been recorded and our team is working hard for you. We will contact you with further steps.